SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (Nasdaq: SNTS), a specialty pharmaceutical company focused on therapies for gastrointestinal diseases and disorders, today announced that Gerald T. Proehl, president and chief executive officer, will make presentations at the following investment conferences during the month of November:
